Lilly Symposium

Lilly are a medicine company turning science into healing to make life better for people around the world. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world’s most significant health challenges. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: “Take what you find here and make it better and better.”

You’re invited to the Lilly lunch symposium at Breast Cancer Trials 45th Annual Scientific Meeting. The primary guest speaker at the Lilly lunch symposium will be Dr Erica Mayer, Director of Clinical Research and an Institute Physician in the Breast Oncology Center at the Dana-Farber Cancer Institute, as well as an Associate Professor in Medicine at Harvard Medical School. More information will be made available in the near future.

For those registered for the symposium, we invite you to give an oral presentation, from the floor, of brief clinical cases of ER+/HER2- metastatic breast cancer for discussion by the panel. No slides are required for audience presentations. Please come prepared with your challenging cases.